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Multimodality Minimally Invasive Treatment of
Large Joint Osteoarthritis: A Pilot Trial of Stromal
Vascular Fraction from Autologous Fat Combined
with Platelet-Rich Plasma
Philip Giddings, Insiyah Campwala, Subhas Gupta
INTRODUCTION
Osteoarthritis (OA) is a degenerative
joint disease that can cause severe pain in those
affected. Currently, there are no therapeutic
drugs available to treat osteoarthritis. While total
joint arthroplasties (TJA) allow for improved
function, there are no less invasive, yet effective
procedures that can be done for patients
unwilling or unable to undergo major surgery.
Platelet-rich plasma (PRP) has been
shown to reduce the symptoms of OA when
injected into the affected joint. Patients treated
by this method alone have improved selfreported pain (at least a 50% reduction from
original value) as well as lower extremity
function. While the effects of PRP treatment on
OA have been positive, treatment with SVF
offers additional benefits that PRP alone cannot.
SVF contains a significant amount of
mesenchymal stem cells (MSC), which have
great potential in the field of regenerative
medicine. The potential to generate new
cartilage in osteoarthritic joints goes beyond
treatment of the symptoms offering a reversal of
the harmful pathology. Considering the positive
results seen from both SVF and PRP treatment,
the reduced risk of surgical complication when
compared to TJA, and the possibility for equal
or greater pain improvement and joint
functionality compared to TJA, we believed it
would be advantageous to investigate a
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combined PRP and SVF therapy for relief of
both mild and advanced stage OA.

MATERIAL AND METHODS
Patients with moderate osteoarthritis
presenting with severe hip pain were selected for
treatment. After a detailed informed consent
process, patients were taken to the operating
room for the proposed combination treatment.
SVF was isolated using liposuction equipment,
and PRP and SVF were centrifuged
independently. With ultrasound guidance, a
mixture of PRP (10mL) and SVF (10mL) was
injected into the osteoarthritic hip joints of
patients under general anesthesia. The Western
Ontario and McMaster Universities Arthritis
Index (WOMAC) scale was used to assess
patients preoperatively and postoperatively to
assess pain improvement.

RESULTS
WOMAC scores were 67/96
preoperatively, and 17/96 at five weeks post-op.
This indicated a decrease in pain and increased
mobility. The procedure was both efficient—
taking approximately one hour of operative
time—and cost effective. No intraoperative nor
postoperative morbidities were found.

CONCLUSION
This new combination therapy offers a
minimally invasive, low-risk and highsatisfaction treatment for osteoarthritic joints.
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